DSFRX
Price
$35.22
Change
+$0.16 (+0.46%)
Updated
May 8 closing price
Net Assets
1.02B
RGAHX
Price
$71.71
Change
+$0.53 (+0.74%)
Updated
May 8 closing price
Net Assets
283.8B
Ad is loading...

DSFRX vs RGAHX

Header iconDSFRX vs RGAHX Comparison
Open Charts DSFRX vs RGAHXBanner chart's image
Domini Impact Equity Y
Price$35.22
Change+$0.16 (+0.46%)
VolumeN/A
Net Assets1.02B
American Funds Growth Fund of Amer R5E
Price$71.71
Change+$0.53 (+0.74%)
VolumeN/A
Net Assets283.8B
DSFRX vs RGAHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DSFRX vs. RGAHX commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DSFRX is a Buy and RGAHX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RGAHX has more cash in the bank: 284B vs. DSFRX (1.02B). RGAHX pays higher dividends than DSFRX: RGAHX (0.54) vs DSFRX (0.39). DSFRX was incepted earlier than RGAHX: DSFRX (21 years) vs RGAHX (9 years). DSFRX (0.97) is less costly to investors than RGAHX (0.44). RGAHX is a more actively managed with annual turnover of: 25.00 vs. DSFRX (9.00). DSFRX has a lower initial minimum investment than RGAHX: DSFRX (0) vs RGAHX (250). RGAHX annual gain was more profitable for investors over the last year : 3.77 vs. DSFRX (2.47). DSFRX return over 5 years is better than : 56.92 vs. RGAHX (45.05).
DSFRXRGAHXDSFRX / RGAHX
Total Expense Ratio0.800.44182%
Annual Report Gross Expense Ratio0.970.44220%
Fund Existence21 years9 years-
Gain YTD-5.424-2.356230%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets1.02B284B0%
Annual Yield % from dividends0.390.5473%
Returns for 1 year2.473.7766%
Returns for 3 years32.5534.5394%
Returns for 5 years56.9245.05126%
Returns for 10 years-26.16N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OVV35.331.47
+4.34%
Ovintiv
TELA0.990.04
+4.26%
TELA Bio
MITK8.810.35
+4.14%
Mitek Systems
VVOS2.840.11
+4.03%
Vivos Therapeutics
FHB23.640.64
+2.78%
First Hawaiian